Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary Immune Deficiency Disorder”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04350164
What this trial is testing

Romiplostim Treatment for Thrombocytopenia in Patients With Wiskott-Aldrich Syndrome.

Who this might be right for
Wiskott-Aldrich Syndrome
Federal Research Institute of Pediatric Hematology, Oncology and Immunology 67
Testing effectiveness (Phase 2)UnknownNCT03315078
What this trial is testing

Lentiviral Gene Transfer for Treatment of Children Older Than 2 Years of Age With X-Linked Severe Combined Immunodeficiency

Who this might be right for
X-Linked Combined Immunodeficiency Diseases
National Institute of Allergy and Infectious Diseases (NIAID) 13
Post-approval studies (Phase 4)Study completedNCT06908252
What this trial is testing

MAPS PrEP Van Study

Who this might be right for
HIV Infection
Duke University 7
Not applicableStudy completedNCT04107233
What this trial is testing

Using Electronic Medical Record Data to Improve HIV Primary Care

Who this might be right for
Quality of Health CareHIV/AIDSElectronic Health Records
Unity Health Toronto 13
Not applicableStudy completedNCT00226304
What this trial is testing

Evaluation of Brain Lesions in HIV-infected Patients for Diagnosis of Primary Central Nervous System Lymphoma

Who this might be right for
HIV InfectionsLymphoma, AIDS-Related
National Institutes of Health Clinical Center (CC) 120
Large-scale testing (Phase 3)Study completedNCT01175213
What this trial is testing

Tolerability and Safety of Immune Globulin Subcutaneous Solution (IGSC) and rHuPH20 in PID

Who this might be right for
Primary Immunodeficiency Diseases (PID)
Baxalta now part of Shire 66
Large-scale testing (Phase 3)Study completedNCT00619320
What this trial is testing

Reducing HIV: Safer Sex Skill Building in Pregnant Drug Abusing Women

Who this might be right for
HIV InfectionsSubstance Use
Virginia Commonwealth University 380
Not applicableStudy completedNCT04861090
What this trial is testing

A Study in Teenagers and Adults With Hereditary Angioedema (HAE) Type I or Type II Who Use Lanadelumab as Long-Term Prophylaxis

Who this might be right for
Hereditary Angioedema (HAE)
Takeda 207
Not applicableActive Not RecruitingNCT05236764
What this trial is testing

Haploidentical Hematopoietic Cell Transplantation Using TCR Alpha/Beta and CD19 Depletion

Who this might be right for
Acute Lymphoblastic Leukemia in RemissionAcute Myeloid Leukemia in RemissionMyelodysplastic Syndromes+8 more
Baylor College of Medicine 3
Not applicableStudy completedNCT02501057
What this trial is testing

Reducing Alcohol Dependence Among HIV-Positive Individuals

Who this might be right for
Alcohol Dependence
Research Foundation for Mental Hygiene, Inc. 133
Not applicableStudy completedNCT03057119
What this trial is testing

Feasibility of SBIRT-PN

Who this might be right for
Substance UseHIV/AIDSOlder Adults+2 more
Florida State University 86
Large-scale testing (Phase 3)Looking for participantsNCT06954441
What this trial is testing

V-IMMUNE: A Novel Immunoglobulin Therapy for Immunodeficiency

Who this might be right for
ImmunodeficienciesPrimary Immunodeficiencies (PID)Agammaglobulinemia
On Pharma Importadora, Exportadora e Distribuidora de Medicamentos LTDA. 50
Testing effectiveness (Phase 2)Study completedNCT03330795
What this trial is testing

Bilateral Orthotopic Lung Transplant - Bone Marrow Transplant

Who this might be right for
Primary ImmunodeficiencyPID
National Institute of Allergy and Infectious Diseases (NIAID) 5
Testing effectiveness (Phase 2)Ended earlyNCT00490100
What this trial is testing

Treatment for Growth Failure in Patients With X-Linked Severe Combined Immunodeficiency: Phase 2 Study of Insulin-Like Growth Factor-1

Who this might be right for
Growth FailureX-linked Severe Combined Immunodeficiency (XSCID)Growth Hormone Resistence
National Institute of Allergy and Infectious Diseases (NIAID) 6
Early research (Phase 1)Study completedNCT00260702
What this trial is testing

Omalizumab to Treat Hyper-IgE (Job's) Syndrome

Who this might be right for
Hyper-IgE SyndromeJob's Syndrome
National Institute of Allergy and Infectious Diseases (NIAID) 1
Not applicableStudy completedNCT03847753
What this trial is testing

Exploring the Comorbidity Between Mental Disorders and General Medical Conditions

Who this might be right for
Organic, Including Symptomatic, Mental DisordersSubstance UseSchizophrenia+38 more
University of Aarhus 5,940,299
Testing effectiveness (Phase 2)Study completedNCT00782106
What this trial is testing

Study to Determine the Dose of Recombinant Human Hyaluronidase Needed to Infuse a Full Dose of IGIV Subcutaneously

Who this might be right for
Primary Immunodeficiency Diseases (PID)
Baxalta now part of Shire 11
Early research (Phase 1)Ended earlyNCT00006153
What this trial is testing

Effectiveness of Adding Remune to Your Current Anti-HIV Drug Combination

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 45
Post-approval studies (Phase 4)UnknownNCT02490956
What this trial is testing

Diagnostic Immunization With Rabies Vaccine in Patients With PID

Who this might be right for
Primary Immunodeficiency
Chulalongkorn University 40
Testing effectiveness (Phase 2)Study completedNCT00389324
What this trial is testing

A Trial of the Pharmacokinetics, Safety, and Tolerability of Subcutaneous Gamunex® in Primary Immunodeficiency

Who this might be right for
Immunologic Deficiency Syndrome
Grifols Therapeutics LLC 35
Next Page